HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $324 | -6.4% | 314,826 | +5.5% | 0.00% | 0.0% |
Q2 2023 | $346 | +1093.1% | 298,359 | +1402.2% | 0.00% | – |
Q1 2023 | $29 | -43.1% | 19,862 | -3.6% | 0.00% | – |
Q4 2022 | $51 | -99.9% | 20,612 | -2.5% | 0.00% | – |
Q3 2022 | $89,000 | +93.5% | 21,137 | +27.9% | 0.00% | – |
Q2 2022 | $46,000 | -29.2% | 16,522 | +43.4% | 0.00% | – |
Q1 2022 | $65,000 | -38.1% | 11,522 | -0.7% | 0.00% | – |
Q4 2021 | $105,000 | -68.4% | 11,602 | -62.6% | 0.00% | -100.0% |
Q3 2021 | $332,000 | -31.8% | 31,060 | -1.2% | 0.00% | 0.0% |
Q2 2021 | $487,000 | -2.8% | 31,431 | +1.7% | 0.00% | 0.0% |
Q1 2021 | $501,000 | -12.9% | 30,915 | +13.6% | 0.00% | -50.0% |
Q4 2020 | $575,000 | +38.6% | 27,209 | -2.9% | 0.00% | +100.0% |
Q3 2020 | $415,000 | -6.1% | 28,028 | -6.9% | 0.00% | -50.0% |
Q2 2020 | $442,000 | +127.8% | 30,095 | +81.4% | 0.00% | +100.0% |
Q1 2020 | $194,000 | -32.4% | 16,589 | +35.4% | 0.00% | 0.0% |
Q4 2019 | $287,000 | +29.3% | 12,250 | +1.7% | 0.00% | 0.0% |
Q3 2019 | $222,000 | – | 12,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |